ArticleOncotarget2018

Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer.

Yoon Seok Suh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.